Results 31 to 40 of about 28,601 (275)

Effects of Levetıracetam Treatment on the Autonomic Nervous System Functions in Epilepsy Patients

Archives of Epilepsy, 2020
Objectives:Sudden unexpected death in epilepsy patients is considered to be the most significant epilepsy-related cause of death, and this is associated especially with uncontrolled generalized tonic-clonic seizures, cardiac arrhythmia, decreased heart ...
Dilek YILMAZ, Burhanettin ÇİĞDEM
doaj   +1 more source

Advance on synthesis, pharmacokinetics, and pharmacodynamics of the anti-epileptic drug: Levetiracetam [PDF]

E3S Web of Conferences, 2020
Over the past few decades, many patients around the world have suffered from epilepsy, and epilepsy treatment is a long-term process. Thus, the safety and efficacy of medication for epilepsy are of equal importance.
Wang Wei
doaj   +1 more source

Hallucination: A rare complication of levetiracetam theraphy

İstanbul Kuzey Klinikleri, 2017
Levetiracetam is a new antiepileptic drug. In addition to epilepsy, it is also used for treating anxiety disorders and dystonia as well as tardive dyskinesia associated with the use of levodopa and neuroleptic drugs.
Seher Erdogan, Mehmet Bosnak
doaj   +1 more source

Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs

Health Technology Assessment, 2021
Background: Levetiracetam (Keppra®, UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran®, Eisai Co. Ltd, Tokyo, Japan) are licensed as monotherapy for focal epilepsy, and levetiracetam is increasingly used as a first-line treatment for generalised ...
Anthony G Marson, Girvan Burnside, Richard Appleton, Dave Smith, John Paul Leach, Graeme Sills, Catrin Tudur-Smith, Catrin O Plumpton, Dyfrig A Hughes, Paula R Williamson, Gus Baker, Silviya Balabanova, Claire Taylor, Richard Brown, Dan Hindley, Stephen Howell, Melissa Maguire, Rajiv Mohanraj, Philip EM Smith   +18 more
doaj   +1 more source

Add-on Levetiracetam in Children With Refractory Epilepsy: A Systematic Review

Journal of Pediatrics Review, 2016
Context Recently, new anti-epileptic drugs are marketed to be used as an add-on to the traditional drugs in children with refractory epilepsy.
Ali Abbaskhanian, Soheila Shahmohammadi
doaj   +2 more sources

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam [PDF]

Journal of Movement Disorders, 2014
Myoclonus in corticobasal degeneration (CBD) has often been associated with severe and difficult to treat disabilities. Levetiracetam is a new antiepileptic agent with antimyoclonic effects. Herein, we present a 72-year-old woman with clinically probable
Jae Wook Cho, Jae Hyeok Lee
doaj   +1 more source

Levetiracetam differentially alters CD95 expression of neuronal cells and the mitochondrial membrane potential of immune and neuronal cells in vitro

Frontiers in Neurology, 2014
Epilepsy is a neurological seizure disorder that affects over 100 million people worldwide. Levetiracetam, either alone, as monotherapy, or as adjunctive treatment, is widely used to control certain types of seizures. Despite its increasing popularity as
Susannah K Rogers, Lee A Shapiro, Lee A Shapiro, Lee A Shapiro, Richard P Tobin, Benjamin eTow, Aleksej eZuzek, Sanjib eMukherjee, Sanjib eMukherjee, Sanjib eMukherjee, M. Karen eNewell-Rogers, M. Karen eNewell-Rogers   +11 more
doaj   +1 more source

Evaluation of Hemogram Indices of Children with Epilepsy Receiving Short-Term Levetiracetam Treatment

Archives of Epilepsy, 2022
Objective:The effects of levetiracetam on hemogram parameters are comparable with other antiepileptics. This study aimed to compare the effects of levetiracetam monotherapy for at least 6 months on hemogram indices with valproic acid.Methods:Cases aged 6-
Turgay Çokyaman, Tolga Kasap
doaj   +1 more source

Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database

Heliyon, 2023
Objective: We evaluated adherence to and 1-year persistence of two third-generation anti-seizure medications (ASMs), lacosamide and perampanel, in adult patients with focal epilepsy, compared with lamotrigine and levetiracetam.
Siming Chen, Toshiki Fukasawa, Akio Ikeda, Masato Takeuchi, Akihiro Shimotake, Satomi Yoshida, Koji Kawakami   +6 more
doaj   +1 more source

The role of Intravenous Levetiracetam in Treatment of Seizures in Brain Tumor Patients

Frontiers in Neurology, 2013
Levetiracetam, tradename Keppra, is a new second generation antiepileptic drug that is being used increasingly in brain tumor patients. In patients suffering with brain tumors, seizures are one of the leading neurologic complications seen in more than ...
Ekokobe eFonkem, Paul eBricker, Diana eMungall, Jose eAceves, Eromata eEbwe, Wei eTang, Wei eTang, BATOOL F. KIRMANI, BATOOL F. KIRMANI, BATOOL F. KIRMANI   +9 more
doaj   +1 more source